Orphanix Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Orphanix General Information


Developer of drugs for rare diseases. The company formulates drugs for diseases which are not very common among humans.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
  • Peter Roseggerstrasse 41
  • Ried im Innkreis, 4910
  • Austria
+43 0676 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orphanix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 15-Jun-2015 Completed Startup
To view Orphanix’s complete valuation and funding history, request access »

Orphanix Patents

Orphanix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019386241-A1 Aqueous paediatric retinol formulations Pending 26-Nov-2018 0000000000
CA-3117767-A1 Aqueous paediatric retinol formulations Pending 26-Nov-2018 0000000000
EP-3880168-A1 Aqueous paediatric retinol formulations Pending 26-Nov-2018 A61K9/1075

Orphanix Executive Team (1)

Name Title Board Seat Contact Info
Philipp Novak Founder & Chief Executive Officer
To view Orphanix’s complete executive team members history, request access »

Orphanix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
tech2b Accelerator/Incubator 000 0000 000000 0
To view Orphanix’s complete investors history, request access »